Test Price
2,800 AED✅ Home Collection Available
SMPX Gene (Deafness, X-Linked Type 4) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SMPX (الصمم المرتبط بالكروموسوم X من النوع 4) بتقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 Trusted 2026 DHA-Grade Molecular Diagnosis – 99.9% Diagnostic Sensitivity
- Accuracy Guarantee: ISO 9001:2015 certified processing; every base pair verified via NGS and confirmed by clinical geneticists.
- Premium Logistics: Hospital-grade home collection (8 AM–11 PM) with ISO-certified cold-chain transport for Whole Blood, Extracted DNA, or FTA Card samples.
- Clinical Guidance: Complimentary telephonic post-test interpretation session with a genetic counsellor, linked to your ENT/audiologist follow-up.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731 (reply within 2‑hours).
ملخص تنفيذي: اختبار تسلسل جيني دقيق للكشف عن طفرات جين SMPX باستخدام تقنية NGS، بدقة تشخيصية 99.9% عبر معمل حاصل على آيزو 9001:2015. يشمل سحب عينات منزلي مبرد بتوصيل سريع، واستشارة وراثية هاتفية ما بعد الفحص. تغطية تأمينية مباشرة بالتواصل عبر واتساب.
Clinical Overview & Scope
This test sequences the entire SMPX gene using Next‑Generation Sequencing to identify pathogenic variants responsible for X-linked non‑syndromic hearing loss. It enables precise diagnosis, carrier detection, and informed audiological management – rapidly evolving cochlear implant candidacy.
يكشف هذا الفحص عن طفرات جين SMPX المرتبطة بفقدان السمع الوراثي المرتبط بالصبغي X، مما يدعم التشخيص المبكر وخيارات إعادة التأهيل السمعي.
| Feature | Our Test (SMPX NGS) | Closest Alternative (Hearing Loss Panel) |
|---|---|---|
| Precision | Single‑gene full‑coverage NGS with targeted validation | Multi‑gene panel (80+ genes) with variable depth |
| Methodology | Next‑Generation Sequencing (Illumina®) + Sanger confirmation | NGS panel, often without single‑gene reflex |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Price | 2800 AED | ~4500 AED |
Clinical Insight & Safety Mandate
“Early genetic diagnosis of X‑linked hearing loss transforms outcomes. By pinpointing SMPX mutations, we can predict progression, tailor cochlear implant timing, and guide family planning. However, no genetic test replaces a thorough audiological evaluation and must be interpreted within the full clinical picture.”
— Dr. Prabhakar Reddy, ENT Consultant (DHA License: 61713011)
⚠️ Medication Safety Warning
Do not discontinue any prescribed medication (including corticosteroids, antiepileptics, or diuretics) without explicit advice from your physician. This test requires only a blood or DNA sample and does not demand drug cessation.
Patient Exclusion & Emergency Flags
- Exclusion Criteria: Unmanaged coagulopathy (INR >1.5), active systemic infection, inability to provide informed consent (unless legal guardian present), and pregnancy only if strictly needed and with genetic counsellor clearance.
- ER Red Flags: Sudden sensorineural hearing loss with vertigo, tinnitus, or focal neurological signs warrants immediate emergency assessment before genetic testing. The consumer will be directed to the nearest DHA-licensed emergency department.
- Paediatric Protocol (CDS Law 2026): Minors require parental/guardian consent and mandatory pre‑test genetic counselling. Sample collection performed by a certified paediatric phlebotomist.
Frequently Asked Questions
1. What is the SMPX gene deafness test and how does it work?
Snippet: This Next-Generation Sequencing test detects SMPX gene mutations causing X-linked hearing loss with 99.9% accuracy.
We extract DNA from your blood or FTA card, amplify and sequence the full SMPX gene, and compare against clinical databases to classify any variants. Results indicate whether a pathogenic mutation is present, enabling precise genetic counselling and audiological planning.
ما هو اختبار جين SMPX للصمم وكيف يعمل؟
يكتشف تحليل التسلسل الجيني من الجيل التالي طفرات جين SMPX المسببة للصمم الوراثي المرتبط بالكروموسوم X بدقة 99.9%. يُستخلص الحمض النووي من عينة الدم أو بطاقة FTA، ويُحدد وجود الطفرة الوراثية لتوجيه التدخل السمعي والوراثي.
2. How accurate is the test and when will I receive my results?
Snippet: The test achieves 99.9% diagnostic sensitivity for SMPX mutations, with reports available in 3–4 weeks.
All variants are reconfirmed by Sanger sequencing. The report includes a clinical interpretation by a board‑certified geneticist and is delivered via secure link. You can schedule a tele‑consultation to discuss findings.
ما مدى دقة الاختبار ومتى أحصل على النتائج؟
حساسية تشخيصية تصل إلى 99.9%، وتصدر النتائج خلال 3 إلى 4 أسابيع. يتم تأكيد جميع المتغيرات جينياً وتقدم استشارة هاتفية لتفسير التقرير.
3. Can this test be done for children and what consent is needed?
Snippet: Yes, the is suitable for minors under 2026 CDS law with parental consent and genetic counselling.
A paediatric genetic counsellor will meet the family (in‑clinic or via video) to explain the implications and draw a pedigree. Sample collection for minors is performed by a specialist trained in paediatric phlebotomy, ensuring comfort and safety.
هل يمكن إجراء الاختبار للأطفال وما هي شروط الموافقة؟
يُسمح بإجراء الاختبار للقاصرين بموجب قانون حماية بيانات الطفل 2026، بشرط موافقة الوالدين وجلسة استشارة وراثية مسبقة مع أخصائي وراثة سريري.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians